Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises on the sale of Nordic Road Safety
Mandate

Vinge advises on the sale of Nordic Road Safety

December 22, 2023 M&A Automotive, Mobility and Electrification

Vinge has advised the owner of Nordic Road Safety AB in connection with the sale of 85% of the shares to Lagercrantz Group AB. Nordic Road Safety is a leading supplier within development, consultation, sales, project management and installation of permanent road safety in the form of road barrier systems and noise protection and has a turnover of approximately SEK 350 million with an operating profit of approximately SEK 50 million.

The acquisition is subject to regulatory approval.

Vinge's team primarily consisted of Johan Winnerblad, Eléonore Friberg and Narin Melazade.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026